Boualem Moulouel
Colombes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Management of erythropoietic protoporphyria with cholestatic liver disease: A case report.
Journal: Molecular genetics and metabolism reports
Published: August 17, 2023
Evaluation of iron metabolism in hospitalized COVID-19 patients.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: May 11, 2023
Quantification of Urine and Plasma Porphyrin Precursors Using LC-MS in Acute Hepatic Porphyrias: Improvement in Routine Diagnosis and in the Monitoring of Kidney Failure Patients.
Journal: Clinical chemistry
Published: March 08, 2023
Givosiran in acute intermittent porphyria: A personalized medicine approach.
Journal: Molecular genetics and metabolism
Published: October 30, 2021
Iron, Heme Synthesis and Erythropoietic Porphyrias: A Complex Interplay.
Journal: Metabolites
Published: October 29, 2021
Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria.
Journal: Haematologica
Published: July 11, 2019
GLRX5 mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia.
Journal: Molecular genetics and metabolism
Published: October 17, 2018
Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria.
Journal: American journal of human genetics
Published: June 24, 2018
Hepcidin as a Major Component of Renal Antibacterial Defenses against Uropathogenic Escherichia coli.
Journal: Journal of the American Society of Nephrology : JASN
Published: October 24, 2014
Hepcidin regulates intrarenal iron handling at the distal nephron.
Journal: Kidney international
Published: July 02, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026